Spero Therapeutics Inc. (SPRO)
0.63
-0.08 (-10.76%)
At close: Apr 03, 2025, 3:59 PM
0.64
1.84%
After-hours: Apr 03, 2025, 07:56 PM EDT
Spero Therapeutics Revenue
Spero Therapeutics reported an annual revenue of $47.98M, reflecting a -50.4% growth. For the quarter ending September 30, 2024, Spero Therapeutics generated $13.47M in revenue.
Revenue (ttm)
$47.98M
Revenue Growth
-50.4%
Price / Sales Ratio
1.16
Revenue / Employee
$1.5M
Employees
32
Market Cap
34.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 47.98M | -50.40% |
| Dec 31, 2023 | 96.73M | +99.13% |
| Dec 31, 2022 | 48.58M | +166.10% |
| Dec 31, 2021 | 18.26M | +95.67% |
| Dec 31, 2020 | 9.33M | n/a |